Critical Path Institute is a catalyst in the development of new approaches to advance medical innovation and regulatory science.
We achieve this by leading teams that share data, knowledge, and expertise, resulting in sound, consensus-based science. More…
Upcoming Events
-
Jun 14, 2023 - Jun 15, 2023 CeBil Symposium
-
Jun 25, 2023 - Jun 29, 2023 DIA 2023 Global Annual Meeting | ILLUMINATE
-
Jul 21, 2023 - Jul 23, 2023 8th International RASopathies Symposium: Expanding Research and Care Practice through Global Collaboration and Advocacy
-
Aug 29, 2023 Externally-Led Patient Focused Drug Development
Past Events
More Events >>Successes
- COA Qualification from FDA for Asthma Daytime Symptom Diary (ADSD) and Asthma Nighttime Symptom Diary (ANSD)
- Qualification of drug-induced kidney injury (DIKI) clinical safety biomarker, composite measure
- COA Qualification from FDA for the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ)
- C-Path receives COA qualification from FDA for the Symptoms of Major Depressive Disorder Scale (SMDDS)
- C-Path’s PKDOC Secures EMA Qualification Opinion for Enrichment Biomarker in ADPKD
- C-Path’s PKDOC Secures FDA Qualification for Enrichment Biomarker in ADPKD
- Regulatory Support For Autosomal Dominant Polycystic Kidney Disease Biomarker
- C-Path Opportunities Table
- EMA Qualifies ‘Hollow Fiber System’ For Anti-Tuberculosis Drug Development
- FDA and EMA issue first-of-their-kind Letters of Support for two Kidney Biomarkers
News
-
Jun 8, 2023 C-Path and I-ACT Collaborate on EHR Data Transfer
-
Jun 7, 2023 Newcastle University’s John Walton Muscular Dystrophy Research Centre Contributes Data to C-Path’s RDCA-DAP
-
Jun 6, 2023 Shaping the Global Innovation and Access Landscape for Better Paediatric Medicines: C-Path Becomes Official Partner of WHO
-
May 31, 2023 CACNA1A Foundation to Contribute Data to C-Path’s RDCA-DAP, Accelerating Neurological Disease Research and Therapeutic Development
-
May 31, 2023 C-Path’s Transplant Therapeutics Consortium’s Work Highlighted in Recent Publication in the American Journal of Transplantation
-
May 25, 2023 C-Path Welcomes Red Nucleus Clinical